Literature DB >> 9541520

Regional variations in the progression of bone loss in two different mouse osteopenia models.

Y Kobayashi1, S Goto, T Tanno, M Yamazaki, H Moriya.   

Abstract

Differences in trabecular and cortical bone loss have been demonstrated clinically, but differences in bone loss at different skeletal sites remain unclear. We examined regional variations in bone loss histomorphometrically in two strains of mice in which osteopenia progresses spontaneously: tiptoe-walking Yoshimura (twy) mice (from 4 to 37 weeks of age) and senescent ICR mice (from 4 to 88 weeks of age). Morphometrical measurements were obtained to investigate the changes with age in trabecular bone area and anterior cortical bone width in the lumbar vertebral body, trabecular bone area in the tibia, bone area in the parietal bone, and the cortical index in the humerus. Results showed that, in twy mice, trabecular turnover was higher than in ICR mice, and bone loss progressed in the following order: tibial trabecular bone, lumbar trabecular bone, parietal bone, lumbar anterior cortical bone, and the humerus. In ICR mice, bone formation declined after 60 weeks. Bone loss progressed in tibial trabecular bone and the parietal bone at 60 weeks of age, followed by lumbar trabecular bone, lumbar anterior cortical bone, and the humerus at 88 weeks of age. Bone loss varied at each site and between the two mouse strains, with different bone turnover rates. The findings of the present study indicate that special attention should be paid to regional variations in the progression of bone loss associated with differences in pathologic features.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541520     DOI: 10.1007/s002239900455

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  4 in total

1.  Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice.

Authors:  Carlos R Ferreira; Dillon Kavanagh; Ralf Oheim; Kristin Zimmerman; Julian Stürznickel; Xiaofeng Li; Paul Stabach; R Luke Rettig; Logan Calderone; Colin MacKichan; Aaron Wang; Hunter A Hutchinson; Tracy Nelson; Steven M Tommasini; Simon von Kroge; Imke Ak Fiedler; Ethan R Lester; Gilbert W Moeckel; Björn Busse; Thorsten Schinke; Thomas O Carpenter; Michael A Levine; Mark C Horowitz; Demetrios T Braddock
Journal:  J Bone Miner Res       Date:  2021-02-18       Impact factor: 6.741

2.  Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.

Authors:  Ralf Oheim; Kristin Zimmerman; Nathan D Maulding; Julian Stürznickel; Simon von Kroge; Dillon Kavanagh; Paul R Stabach; Uwe Kornak; Steven M Tommasini; Mark C Horowitz; Michael Amling; David Thompson; Thorsten Schinke; Björn Busse; Thomas O Carpenter; Demetrios T Braddock
Journal:  J Bone Miner Res       Date:  2019-12-05       Impact factor: 6.741

3.  Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization.

Authors:  Nathan D Maulding; Dillon Kavanagh; Kristin Zimmerman; Gianfilippo Coppola; Thomas O Carpenter; Nathaniel K Jue; Demetrios T Braddock
Journal:  Bone       Date:  2020-09-24       Impact factor: 4.398

4.  Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification.

Authors:  Robert Terkeltaub
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.